Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
18.64
+0.12 (0.65%)
Nov 21, 2024, 12:43 PM EST - Market open

Company Description

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients’ mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks.

It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies.

The company was incorporated in 2005 and is based in Wilmington, Delaware.

Phreesia, Inc.
Phreesia logo
Country United States
Founded 2005
IPO Date Jul 18, 2019
Industry Health Information Services
Sector Healthcare
Employees 1,438
CEO Chaim Indig

Contact Details

Address:
1521 Concord Pike, Suite 301
Wilmington, Delaware 19803
United States
Phone 888 654 7473
Website phreesia.com

Stock Details

Ticker Symbol PHR
Exchange NYSE
Fiscal Year February - January
Reporting Currency USD
IPO Price $17.00
CIK Code 0001412408
CUSIP Number 71944F106
ISIN Number US71944F1066
SIC Code 7389

Key Executives

Name Position
Chaim Indig Co-Founder, Chief Executive Officer and Director
Evan Roberts Co-Founder and Chief Operating Officer
Balaji Gandhi Chief Financial Officer
David Linetsky Senior Vice President of Life Sciences
Yvonne Hui Vice President and Principal Accounting Officer
Jack Callahan Chief Technology Officer
Maureen McKinney Vice President of Corporate Communications
Ashwin G. Uttamchandani Vice President of Sales and Marketing Operations
Amy Beth VanDuyn Senior Vice President of Human Resources
Dr. Hilary Hatch Ph.D. Chief Clinical Officer

Latest SEC Filings

Date Type Title
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 21, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 18, 2024 144 Filing
Oct 16, 2024 144 Filing
Oct 15, 2024 144 Filing
Oct 15, 2024 144 Filing
Oct 15, 2024 144 Filing
Oct 15, 2024 144 Filing
Oct 15, 2024 144 Filing